FAQs & Contact
Japanese
About Chugai
Innovation
Sustainability
Stories
Investor Relations
News Room
Recruitment
FAQs & Contact
Japanese
Home
About Chugai
News
Recombinant Human Erythropoietin,“EPOGIN® Subcutaneous Injection Syringe 24000,” Approved in Japan
Jun 18, 2010
Recombinant Human Erythropoietin,“EPOGIN
®
Subcutaneous Injection Syringe 24000,” Approved in Japan
[PDF 187KB]
Back
Home
About Chugai
News
Recombinant Human Erythropoietin,“EPOGIN® Subcutaneous Injection Syringe 24000,” Approved in Japan
You are now moving to an external website.
Access the link